<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31519375</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-3405</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>20</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Bioorganic &amp; medicinal chemistry letters</Title><ISOAbbreviation>Bioorg Med Chem Lett</ISOAbbreviation></Journal><ArticleTitle>Glycyrrhizic acid derivatives as Dengue virus inhibitors.</ArticleTitle><Pagination><StartPage>126645</StartPage><MedlinePgn>126645</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bmcl.2019.126645</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0960-894X(19)30590-6</ELocationID><Abstract><AbstractText>Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1&#x202f;&#x3bc;M. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2-1.3&#x202f;&#x3bc;M). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baltina</LastName><ForeName>Lidia A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71, Prospect Oktyabrya, Ufa 450054, Russian Federation. Electronic address: baltina@anrb.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasi</LastName><ForeName>Yan-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, 91, Hsueh-Shih Rd., Taichung 40402, Taiwan, ROC; Department of Biotechnology, Asia University, 500, Lioufeng Rd., Wufeng, Taichung 41354, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Su-Hua</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Asia University, 500, Lioufeng Rd., Wufeng, Taichung 41354, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Hsueh-Chou</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>School of Chinese Medicine, China Medical University, 91, Hsueh-Shih Rd., Taichung 40402, Taiwan, ROC; Division of Hepato-gastroenterology, Department of Internal Medicine, China Medical University Hospital, 2, Yude Rd., Taichung 40447, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baltina</LastName><ForeName>Lia A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71, Prospect Oktyabrya, Ufa 450054, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrova</LastName><ForeName>Svetlana F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71, Prospect Oktyabrya, Ufa 450054, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunusov</LastName><ForeName>Marat S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Ufa Institute of Chemistry, Ufa Federal Research Centre of RAS, 71, Prospect Oktyabrya, Ufa 450054, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Cheng-Wen</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, 91, Hsueh-Shih Rd., Taichung 40402, Taiwan, ROC; Department of Biotechnology, Asia University, 500, Lioufeng Rd., Wufeng, Taichung 41354, Taiwan, ROC; Chinese Medicine Research Center, China Medical University, 91, Hsueh-Shih Rd., Taichung 40402, Taiwan, ROC. Electronic address: cwlin@mail.cmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioorg Med Chem Lett</MedlineTA><NlmUniqueID>9107377</NlmUniqueID><ISSNLinking>0960-894X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance></Chemical><Chemical><RegistryNumber>6FO62043WK</RegistryNumber><NameOfSubstance UI="D019695">Glycyrrhizic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019695" MajorTopicYN="N">Glycyrrhizic Acid</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral activity</Keyword><Keyword MajorTopicYN="N">Dengue virus</Keyword><Keyword MajorTopicYN="N">Derivatives</Keyword><Keyword MajorTopicYN="N">Glycyrrhizic acid</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31519375</ArticleId><ArticleId IdType="pmc">PMC7172207</ArticleId><ArticleId IdType="doi">10.1016/j.bmcl.2019.126645</ArticleId><ArticleId IdType="pii">S0960-894X(19)30590-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kyle J.L., Harris E. Global spread and persistence of dengue. Annu Rev Microbiol. 2008;62:71&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">18429680</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Halstead S.B., Artsob H., et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;12:S7&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D.J. Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop Med Health. 2011;39:3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3317603</ArticleId><ArticleId IdType="pubmed">22500131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Ooi E.-E., Vasudevan S.G., Gubler D.J. Update on Dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep. 2010;12:157&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">21308524</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons C.P., Farrar J.J., Chau N., Wills B. Dengue. N Engl J Med. 2012;366:1423&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Dengue: Guedelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization; 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">23762963</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P., Fuchs A., Hauhart R.E., et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010;207:793&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856034</ArticleId><ArticleId IdType="pubmed">20308361</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M.S., Pierson T.C. Molecular insight into Dengue virus pathogenesis and its implications for disease control. Cell. 2015;162:488&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522276</ArticleId><ArticleId IdType="pubmed">26232221</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens A.J., Gahan M.E., Mahalingam S., Keller P.A. The medicinal chemistry of dengue fever. J Med Chem. 2009;52:7911&#x2013;7926.</Citation><ArticleIdList><ArticleId IdType="pubmed">19739651</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Dengue vaccine development: a 75% solution? Lancet. 2012;380:1535&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pubmed">22975339</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez J.P., Sasse F., Bronstrup M., Diez J., Meyerhans A. Antiviral drug discovery: broad-spectrum drugs from nature. Nat Prod Rep. 2015;32:29&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">25315648</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes E.C., Kumar R., Davis R.A. The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery. Nat Prod Rep. 2016;33:372&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">26739749</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompei R., Laconi S., Ingianni A. Antiviral properties of Glycyrrhizic acid and its semisynthetic derivatives. Mini Rev Med Chem. 2009;9:996&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">19601894</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Kondratenko R.M., Baltina L.A., Jr., Plyasunova O.A., Pokrovskyi A.G., Tolstikov G.A. Prospects for the creation of new antiviral drugs based on Glycyrrhizic acid and its derivatives. Pharm Chem J. 2009;43:539&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089237</ArticleId><ArticleId IdType="pubmed">32214533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato H., Goto W., Yamamura J., et al. Therapeutic basis of glycyrrhizin in chronic hepatitis B. Antiviral Res. 1996;30:171&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">8783808</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto Y., Matsuura T., Aoyagi H., et al. Antiviral activity of Glycyrrhizin against hepatitis C virus in vitro. PLoS One. 2013;8:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715454</ArticleId><ArticleId IdType="pubmed">23874843</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clerq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev. 2000;20:323&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">10934347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratenko R.M., Baltina L.A., Baltina L.A., Jr., Plyasunova O.A., Pokrovskyi A.G., Tolstikov G.A. Synthesis of new hetero- and carbocyclic aromatic amides of Glycyrrhizic acid as potential anti-HIV agents. Pharm Chem J. 2009;43:383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089237</ArticleId><ArticleId IdType="pubmed">32214533</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L. Chemical modification of Glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem. 2003;10:155&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">12570715</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrovskyi A.G., Belanov E.F., Volkov G.N., Plyasunova O.A., Tolstikov G.A. Inhibition of Marburg virus reproduction by Glycyrrhizic acid and its derivatives. Reports RAS. 1995;344:709&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">8563649</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoever G., Baltina L.A., Michaelis M., Kondratenko R., Baltina L.A., Jr., Tolstikov G.A. Antiviral activity of Glycyrrhizic acid derivatives against SARS-Coronavirus. J Med Chem. 2005;48:1256&#x2013;1259.</Citation><ArticleIdList><ArticleId IdType="pubmed">15715493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.C., Cherng J.M., Hung M.S., Baltina L.A., Baltina L.A., Kondratenko R.M. Inhibitory effects of some derivatives of Glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships. Antiviral Res. 2008;79:6&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114209</ArticleId><ArticleId IdType="pubmed">18423902</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Zarubaev V.V., Baltina L.A., et al. Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors. Bioorg Med Chem Lett. 2015;25:1742&#x2013;1746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127794</ArticleId><ArticleId IdType="pubmed">25801933</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayrushina A.I., Baltina L.A., Jr., Baltina L.A., Konovalova N.I., Petrova P.A., Eropkin M.Y. Synthesis and antiviral activity of novel Glycyrrhizic acid conjugates with d-aminoacids. Russ J Bioorg Chem. 2017;43:456&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088872</ArticleId><ArticleId IdType="pubmed">32214781</ArticleId></ArticleIdList></Reference><Reference><Citation>Crance J.M., Scaramozzino N., Jouan A., Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 2003;58:73&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">12719009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratenko R.M., Baltina L.A., Mustafina S.R., Makarova N.V., Nasyrov K.M., Tolstikov G.A. Crystalline Glycyrrhizic acid synthesized from commercial Glycyrrham. Immunomodulant properties of high-purity Glycyrrhizic acid. Pharm Chem J. 2001;35:101&#x2013;104.</Citation></Reference><Reference><Citation>Tolstikov G.A., Baltina L.A., Grankina V.P., Kondratenko R.M., Tolstikova T.G. Academic Publishing House &#x201c;Geo&#x201d;; Novosibirsk: 2007. Licorice: Biodiversity, Chemistry, Application in Medicine; p. 311.</Citation></Reference><Reference><Citation>Baltina L.A., Kunert O., Fatykhov A.A., et al. High-resolution 1H and 13C NMr of Glycyrrhizic acid and its esters. Chem Nat Compd. 2005;41:432&#x2013;435.</Citation></Reference><Reference><Citation>Baltina L.A., Jr., Fairushina A.I., Baltina L.A., et al. Synthesis and antiviral activity of Glycyrrhizic acid conjugates with aromatic amino acids. Chem Nat Compd. 2017;53:1096&#x2013;1100.</Citation></Reference><Reference><Citation>Baltina L.A., Jr., Fairushina A.I., Baltina L.A. New methods of preparation of carboxy-protected amino acid conjugates of Glycyrrhizic acid. Russ J Gen Chem. 2016;86:826&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7104129</ArticleId><ArticleId IdType="pubmed">32288468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratenko R.M., Baltina L.A., Jr., Baltina L.A., Baschenko N.Z., Tolstikov G.A. Synthesis and immunomodulating activity of new glycopeptides of Glycyrrhizic acid containing residues of l-glutamic acid. Russ J Bioorg Chem. 2006;32:595&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pubmed">17180917</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Jr., Fairushina A.I., Baltina L.A. Synthesis of amino acid conjugates of Glycyrrhizic acid using N-hydroxyphthalimide and N,N&#x2032;-dicyclohexylcarbodiimide. Russ J Gen Chem. 2015;85:2735&#x2013;2738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7104134</ArticleId><ArticleId IdType="pubmed">32288467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryzhova S.A., Baltina L.A., Tolstikov G.A. Transformations of Glycyrrhizic acid. XI. Synthesis of free glycopeptides. Russ J Gen Chem. 1996;66:157&#x2013;159.</Citation></Reference><Reference><Citation>Baltina L.A., Jr., Chistoedova E.S., Baltina L.A., Kondratenko R.M., Plyasunova O.A. Synthesis and anti-HIV-1 activity of new conjugates of 18&#x3b2;- and 18&#x3b1;-Glycyrrhizic acids with aspartic acid esters. Chem Nat Compd. 2012;48:262&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088273</ArticleId><ArticleId IdType="pubmed">32214422</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltina L.A., Jr., Stolyarova O.V., Baltina L.A., et al. New amino-acid conjugates of Glycyrrhizic acid. Chem Nat Compd. 2014;50:317&#x2013;320.</Citation></Reference><Reference><Citation>Lien J.C., Wang C.Y., Lai H.C., et al. Structure analysis and antiviral activity of CW-33 analogues against Japanese encephalitis virus. Sci Rep. 2018;8:16595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6226475</ArticleId><ArticleId IdType="pubmed">30413749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>